CASP8 and cancer: In the cholangiocarcinoma model, treatment of both SMAC-mimetic (LCL161 and DEBIO1143) and TNF sensitizes cancer cells to a low dose of gemcitabine-induced necrosome complex formation and necroptosis upon the loss of cIAPs and caspase-8 function [303].